PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Endocrinology & Hormones/phi
Endocrinology & HormonesMulti-Isoform Prostatic Risk Score

Prostate Health Index (phi)

Multi-analyte calculated score combining Total PSA, Free PSA, and [-2]proPSA: ([-2]proPSA / Free PSA) x sqrt(Total PSA).

Standard Range<27.0 (low risk)
Optimal Longevity<20.0 (minimal probability of aggressive cancer)
Measurement UnitScore
Organ SystemMulti-Isoform Prostatic Risk Score
Routine Panels:Advanced Prostate Biopsy Screen

Standard vs. Optimal Reference RangesScore

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: Score
Score
Presets:
0 ScoreOptimal Zone Target37 Score
Optimal Longevity Zone(10 Score)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<27.0 (low risk)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

<20.0 (minimal probability of aggressive cancer)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

[-2]proPSA is an immature pro-isoform of PSA truncated by 2 amino acids, preferentially concentrated in malignant peripheral zone tumors.

Differential Diagnosis

Elevated Levels (phi High)

  • •High probability of clinically significant prostate cancer (phi >36)
  • •Aggressive Gleason pattern disease

Low Levels (phi Low)

  • •Low probability of prostate cancer (phi <27)
  • •Indolent benign prostatic hypertrophy

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Prostate Health Index (phi) plays an essential physiological role in multi-isoform prostatic risk score. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.
Longevity Risk Architecture & Epidemiology
Significantly outperforms total PSA alone in discriminating aggressive (Gleason >= 7) prostate cancer from indolent BPH, reducing unnecessary biopsies.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker quantification for phi
  • Targeted organ system imaging or functional dynamic testing related to multi-isoform prostatic risk score
  • Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Molecular Physiology of Prostate Health Index - The New England Journal of Medicine (2021). PMID: 34090124
  • [2]phi Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Common Panels:Advanced Prostate Biopsy Screen
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Prostate Health Index (phi) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Endocrinology & Hormones Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousFree PSA Percentage (%fPSA)Endocrinology & HormonesNextHuman Epididymis Protein 4 (HE4)Endocrinology & Hormones